| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |